| [1] |
Yeo B, Turner NC, Jones A. An update on the medical management of breast cancer[J]. BMJ, 2014, 348: g3608.
|
| [2] |
Jia LT, Chen SY, Yang AG. Cancer gene therapy targeting cellular apoptosis machinery[J]. Cancer Treat Rev, 2012, 38(7): 868-76.
|
| [3] |
Ortiz R, Melguizo C, Prados J, et al. New gene therapy strategies for cancer treatment: a review of recent patents[J]. Recent Pat Anticancer Drug Discov, 2012, 7(3): 297-312.
|
| [4] |
Ghersevich S, Ceballos MP. Mammaglobin A: review and clinical utility[J]. Adv Clin Chem, 2014, 64: 241-68.
|
| [5] |
Al Joudi FS. Human mammaglobin in breast cancer: a brief review of its clinical utility[J]. Indian J Med Res, 2014, 139(5): 675-85.
|
| [6] |
Galvis-Jimenez JM, Curtidor H, Patarroyo MA, et al. Mammaglobin peptide as a novel biomarker for breast cancer detection[J]. Cancer Biol Ther, 2013, 14(4): 327-32.
|
| [7] |
Shi CX, Long MA, Liu L, et al. The human SCGB2A2 (mammaglobin-1) promoter/enhancer in a helper-dependent adenovirus vector directs high levels of transgene expression in mammary carcinoma cells but not in normal nonmammary cells[J]. Mol Ther, 2004, 10(4): 758-67.
|
| [8] |
Dentice M, Luongo C, Elefante A, et al. Transcription factor Nkx-2.5 induces sodium/iodide symporter gene expression and participates in retinoic acid- and lactation-induced transcription in mammary cells[J]. Mol Cell Biol, 2004, 24(18): 7863-77.
|
| [9] |
Wan M, Huang W, Kute TE, et al. Yin Yang 1 plays an essential role in breast cancer and negatively regulates p27[J]. Am J Pathol, 20 12, 180(5): 2120-33.
|
| [10] |
Lee MH, Lahusen T, Wang RH, et al. Yin Yang 1 positively regulates BRCA1 and inhibits mammary cancer formation[J]. Oncogene, 2012, 31(1): 116-27.
|
| [11] |
Lu Q, Ye X, Liu F, et al. Homologous recombination-based adenovirus vector system for tumor cell-specific gene delivery[J]. Cancer Biol Ther, 2013, 14(8): 728-35.
|
| [12] |
Fang L, Shanqu L, Ping G, et al. Gene therapy with RNAi targeting UHRF1 driven by tumor-specific promoter inhibits tumor growth and enhances the sensitivity of chemotherapeutic drug in breast cancer in vitro and in vivo[J]. Cancer Chemother Pharmacol, 2012, 69(4): 1079-87.
|
| [13] |
Sinn BV, von Minckwitz G, Denkert C, et al. Evaluation of Mucin-1 protein and mRNA expression as prognostic and predictive markers after neoadjuvant chemotherapy for breast cancer[J]. Ann Oncol, 2013, 24(9): 2316-24.
|
| [14] |
Huyn ST, Burton JB, Sato M, et al. A potent, imaging adenoviral vector driven by the cancer-selective mucin-1 promoter that targets breast cancer metastasis[J]. Clin Cancer Res, 2009, 15(9): 31 26-34.
|
| [15] |
Miksicek RJ, Myal Y, Watson PH, et al. Identification of a novel breast- and salivary gland-specific, mucin-like gene strongly expressed in normal and tumor human mammary epithelium[J]. Cancer Res, 2002, 62(10): 2736-40.
|
| [16] |
Bao R, Connolly DC, Murphy M, et al. Activation of cancerspecific gene expression by the survivin promoter[J]. J Natl Cancer Inst, 2002, 94(7): 522-8.
|
| [17] |
Nicholson S, Whitehouse H, Naidoo K, et al. Yin Yang 1 in human cancer[J]. Crit Rev Oncog, 2011, 16(3-4): 245-60.
|
| [18] |
Hamamoto H, Hasegawa K, Nakaune R, et al. Tandem repeat of a transcriptional enhancer upstream of the sterol 14alphademethylase gene (CYP51) in Penicillium digitatum[J]. Appl Environ Microbiol, 2000, 66(8): 3421-6.
|
| [19] |
Park BJ, Brown CK, Hu Y, et al. Augmentation of melanomaspecific gene expression using a tandem melanocyte-specific enhancer results in increased cytotoxicity of the purine nucleoside phosphorylase gene in melanoma[J]. Hum Gene Ther, 1999, 10 (6): 889-98.
|
| [20] |
Latham JP, Searle PF, Mautner V, et al. Prostate-specific antigen promoter/enhancer driven gene therapy for prostate cancer: construction and testing of a tissue-specific adenovirus vector[J]. Cancer Res, 2000, 60(2): 334-41.
|
| [21] |
Siders WM, Halloran PJ, Fenton RG. Transcriptional targeting of recombinant adenoviruses to human and murine melanoma cells [J] Cancer Res, 1996, 56(24): 5638-46.
|
下载:
